4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient’s interest to do so, with regard to the quality, safety, and efficacy of care, and only …

Supraventricular arrhythmias are common and patients are often symptomatic, requiring
management with drugs and electrophysiological procedures. The ESC published management …

… Lambiase … Lambiase … Lambiase has received speaker fees and research support
from Boston Scientific, Medtronic, St. Jude Medical, and UCLH Biomedicine NIHR. …

Aims The totally subcutaneous implantable-defibrillator (S-ICD) is a new alternative to the
conventional transvenous ICD system to minimize intravascular lead complications. There are …

Background The subcutaneous implantable cardioverter–defibrillator (ICD) was designed to
avoid complications related to the transvenous ICD lead by using an entirely extrathoracic …

… Lambiase has received speaker fees and research support from Boston Scientific, Medtronic,
St. Jude Medical, and University College London Hospitals Biomedicine National Institute …

The ‘Lambeth Conventions’ is a guidance document, written in 1987 (Walker et al., 1988),
intended to be of practical value in the investigation of experimental arrhythmias induced by …

… Dr Lambiase receives research grants and speaker fees from Boston Scientific, Abbott and
Medtronic; and is supported by University College of London/University College of London …

Brugada syndrome (BrS) is a cardiac arrhythmia disorder associated with sudden death in
young adults. With the exception of SCN5A, encoding the cardiac sodium channel Na V 1.5, …

Aims Anecdotal observations suggest that sub-clinical electrophysiological manifestations
of arrhythmogenic right ventricular cardiomyopathy (ARVC) develop before detectable …